How is 5-amino-1MQ dosed and mixed?
Draw to
unitsmL
0.3 mL · 30 units syringe0.5 mL · 50 units syringe1 mL · 100 units syringe3 mL · 3cc syringe0.5 mL · 20 units, U-40 syringe1 mL · 40 units, U-40 syringe
Concentration is the powder in the vial divided by the water. The draw is the dose divided by the concentration, in mL, times 100 on a U-100 syringe or 40 on a U-40. Every figure comes from what you enter.
Save to Milligram
Open in Milligram shows once the calculator has a result.
Open in Milligram is off while the dose is more than the whole vial. Check the dose and its unit.
Open in Milligram is off while the draw is under one unit. Check the dose and its unit.
Open in Milligram adds 5-Amino-1MQ and this dose to a plan in the app, with the schedule you pick here. The vial and water are not saved.
DailyMed lists no label for 5-amino-1MQ, mouse studies gave it under the skin at 10 or 32 mg/kg a day (Babula and colleagues, 8 mice per group) and about 34 mg/kg a day (Neelakantan and colleagues, 9 mice per group), and 40% of the people who logged it in Milligram logged a 5 mg dose.1238
The guide's example
5 mg of 5-Amino-1MQ from a 50 mg vial mixed with 3 mL is 30 units on a U-100 syringe.
Every vial at a glance. Pick a cell to draw it on the syringe.
| Vial | 2 mL of water | 3 mL of water |
|---|---|---|
| 50 mg69% set up8 | 25 mg/mL: 2.5 mg is 10 units, 5 mg is 20 units | 16.667 mg/mL: 2.5 mg is 15 units, 5 mg is 30 units |
Most often logged by Milligram users: 5 mg, 40% logged.8
How do people set up a 5-amino-1MQ vial?
Of the people who logged 5-amino-1MQ, 69% set up a 50 mg vial and 22% a 10 mg vial.8 The mix logged most often is 50 mg with 3 mL (26%).8 Smaller shares set up 50 mg with 2 mL (19%) and 10 mg with 2 mL (13%).8 Of the people who logged 5-amino-1MQ, 40% logged a 5 mg dose and 13% a 2.5 mg dose.8
5 mg of 5-Amino-1MQ from a 50 mg vial mixed with 3 mL is 30 units on a U-100 syringe.
26% set up 50 mg + 3 mL8
What do the sources say about dose?
DailyMed searches under two names returned no label.14 A ClinicalTrials.gov search for the compound as an intervention returned an empty list.5 Animal doses are given per kg of body weight, and none is a human dose.
| Study | Dose and schedule | Animals | Length |
|---|---|---|---|
| Neelakantan and colleagues, obesity study3 | 20 mg/kg per injection, three subcutaneous injections a day (about 34 mg/kg a day) | Diet-induced obese mice, 9 per group | 11 days |
| Neelakantan and colleagues, aged-mice study6 | 5 or 10 mg/kg, twice-daily subcutaneous injections for 2 weeks; 10 mg/kg only in the 4-week group | 24-month-old male mice: 10 and 13 per group (2 weeks), 6 per group (4 weeks) | 2 weeks, and 4 weeks in a separate group |
| Babula and colleagues2 | 10 or 32 mg/kg a day, one subcutaneous injection daily | Diet-induced obese mice, eight per group | 30 days in the methods, 28 days in the paper's summary |
Is it injected or oral?
Of the people who logged a route, 82% logged under the skin, 9% oral and 9% muscle.8 The app's own entry for 5-amino-1MQ lists oral, and 9% of the people who logged a route logged oral.8 Babula and colleagues also gave mice 5 mg/kg intravenously and 30 mg/kg by mouth (3 mice each) to measure blood levels.2 In rats, Awosemo and colleagues report an oral bioavailability of 38.4%; the PubMed record gives no dose or number of rats.7
How is it stored?
Babula and colleagues made up the compound weekly for their mouse study by dissolving it in 0.9% sterile saline and filtering it through a 0.2 micrometre membrane, and stored the solutions at 4 degrees C.2
Frequently asked questions
What water is used to mix 5-amino-1MQ?
The mouse study of Babula and colleagues dissolved the compound in 0.9% sterile saline.2
How the logged figures are counted
Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people.
References
- DailyMed, US National Library of Medicine. DailyMed label search for 5-amino-1MQ, run 2026-11-17. 2026. dailymed.nlm.nih.gov
- Diabetes, Obesity and Metabolism (Babula et al.). Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction. 2024. pmc.ncbi.nlm.nih.gov
- Biochemical Pharmacology (Neelakantan et al.). Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. 2018. pmc.ncbi.nlm.nih.gov
- DailyMed, US National Library of Medicine. DailyMed label search for 5-amino-1-methylquinolinium, run 2026-11-17. 2026. dailymed.nlm.nih.gov
- ClinicalTrials.gov, US National Library of Medicine. ClinicalTrials.gov search for 5-amino-1MQ, 5-amino-1-methylquinolinium or 5A1MQ, run 2026-11-17. 2026. clinicaltrials.gov
- Biochemical Pharmacology (Neelakantan et al.). Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. 2019. pmc.ncbi.nlm.nih.gov
- Journal of Pharmaceutical and Biomedical Analysis (Awosemo et al.). Development & validation of LC-MS/MS assay for 5-amino-1-methyl quinolinium in rat plasma. 2021. pubmed.ncbi.nlm.nih.gov
- Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people. How these figures are counted